alrizomadlin,pembrolizumab
gilead sciences,ascentage pharmaceuticals,merck
['solid tumor', 'ascent', 'alrizomadlin', 'apg-115', 'pembro']
dcbn news: asco 2022 | ascentage pharma releases updated results demonstrating the therapeutic potential of alrizomadlin (apg-115) plus pembrolizumab in patients with solid tumors who progressed on ... #biotech #news 
Life science news and jobs from Washington DC, Maryland and Virginia. Part of @BiotechNetworks, connecting #biotech since 2008.